You are here: Industry Insights > CDMO

News List

COVID-19 is benefiting contract manufacturing services, suggest reports europeanpharmaceuticalreview
November 19, 2020
Reports have found that the COVID-19 pandemic is providing new opportunities for contract and development manufacturing organisations (CDMOs).
Bionova Scientific Secures First Client Commitment contractpharma
November 19, 2020
Bionova Scientific, a biologics CDMO with extensive protein production, cell line development, process development and analytical expertise, has secured its first client commitment for GMP clinical supply.
Cambrex Expands API Mfg. Capacity in Charles City contractpharma
November 18, 2020
Cambrex is expanding its mid-scale and large-scale API manufacturing capacity in Charles City, Iowa. The $50+ million investment aims to meet growing demand for small molecule drug substance development and manufacturing.
Vibalogics Establishes U.S. Presence contractpharma
November 17, 2020
Vibalogics, a global contract development and manufacturing organization (CDMO), has initiated Phase I of its planned $150 million investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, MA.
AzurRx BioPharma Partners with Asymchem contractpharma
November 13, 2020
Will develop and produce MS1819 for the treatment of exocrine pancreatic insufficiency.
Porton Biologics Launches Gene and Cell Therapy CDMO Platform contractpharma
November 06, 2020
Commercial manufacturing base settled in Suzhou BioBAY for the development of pharmaceuticals.
COVID-19 is driving more supplier redundancy expresspharma
November 06, 2020
Contract development and manufacturing organisations (CDMOs) are busier than ever, and their work will increase as the pandemic prompts pharma companies to increase redundancy in the supply chain, says GlobalData.
CDMO Minaris Invests $64.5M to Expand Operations contractpharma
November 05, 2020
To significantly expand manufacturing capacity for cell and gene therapies in Germany and Japan.
3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement contractpharma
October 28, 2020
3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has signed a manufacturing agreement with SpyBiotech, a company with a novel vaccine platform to..
CDMO Frontida Strengthens Quality Operations contractpharma
October 28, 2020
Frontida BioPharm, Inc., a minority-owned contract development and manufacturing organization (CDMO), has appointed Steven Roese as Vice President of Quality. Mr. Roese joins Frontida with over 25 years of experience in quality operations and ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page